Issue 3/2021
Content (36 Articles)
A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management
Hely Shah, Julian Surujballi, Arif Ali Awan, Brian Hutton, Angel Arnaout, Risa Shorr, Lisa Vandermeer, Mashari Jemaan Alzahrani, Mark Clemons
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer
Mei-Yin C. Polley, Roberto A. Leon-Ferre, Samuel Leung, Angela Cheng, Dongxia Gao, Jason Sinnwell, Heshan Liu, David W. Hillman, Abraham Eyman-Casey, Judith A. Gilbert, Vivian Negron, Judy C. Boughey, Minetta C. Liu, James N. Ingle, Krishna Kalari, Fergus Couch, Jodi M. Carter, Daniel W. Visscher, Torsten O. Nielsen, Matthew P. Goetz
Is axillary imaging for invasive lobular carcinoma accurate in determining clinical node staging?
Katelyn Schumacher, Marc Inciardi, Maura O’Neil, Jamie L. Wagner, Ishani Shah, Amanda L. Amin, Christa R. Balanoff, Kelsey E. Larson
Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution
Xiaoxian Li, Zhongliang Ma, Toncred M. Styblo, Cletus A. Arciero, Haibo Wang, Michael A. Cohen
Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients
Vanessa Lattimore, Michael T. Parsons, Amanda B. Spurdle, John Pearson, Klaus Lehnert, Jan Sullivan, Caroline Lintott, Suzannah Bawden, Helen Morrin, Bridget Robinson, Logan Walker
Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancer
Andrea Chobrutskiy, Boris I. Chobrutskiy, Saif Zaman, Monica Hsiang, George Blanck
The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer
Romain Tropée, Bárbara de la Peña Avalos, Madeline Gough, Cameron Snell, Pascal H. G. Duijf, Eloïse Dray
Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer
Khloud A. Elsharawy, Maryam Althobiti, Omar J. Mohammed, Abrar I. Aljohani, Michael S. Toss, Andrew R. Green, Emad A. Rakha
Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy
Shiwei Liu, Shiyan Zeng, Li Xia, Miao Yu, Xin Zhang, Hong Yang, Juan Ji, Hao Dong, Jianhui Zhang, Purong Zhang
Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA)
Katherine Clifton, Jingqin Luo, Yu Tao, Jennifer Saam, Thereasa Rich, Anna Roshal, Ashley Frith, Caron Rigden, Foluso Ademuyiwa, Katherine Weilbaecher, Leonel Hernandez-Aya, Lindsay L. Peterson, Nusayba Bagegni, Rama Suresh, Ron Bose, Mateusz Opyrchal, Tanya M. Wildes, Cynthia Ma
Patterns of biomarker expression in patients treated with primary endocrine therapy – a unique insight using core needle biopsy tissue microarray
R. M. Parks, M. A. Albanghali, B. M. Syed, A. R. Green, I. O. Ellis, K-L. Cheung
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
Amparo Garcia-Tejedor, Sergi Fernandez-Gonzalez, Raul Ortega, Miguel Gil-Gil, Hector Perez-Montero, Eulalia Fernandez-Montolí, Agostina Stradella, Sabela Recalde, Teresa Soler, Anna Petit, Maria Teresa Bajen, Ana Benitez, Anna Guma, Miriam Campos, Maria J. Pla, Evelyn Martinez, Maria Laplana, Sonia Pernas, Diana Perez-Sildekova, Isabel Catala, Jordi Ponce, Catalina Falo
The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis
Roi Weiser, Waqar Haque, Efstathia Polychronopoulou, Sandra S. Hatch, Yong-fang Kuo, William J. Gradishar, V. Suzanne Klimberg
To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?
S. L. Herbert, A. Wöckel, R. Kreienberg, T. Kühn, F. Flock, R. Felberbaum, W. Janni, C. Curtaz, M. Kiesel, T. Stüber, J. Diessner, J. Salmen, L. Schwentner, V. Fink, I. Bekes, E. Leinert, K. Lato, A. Polasik, F. Schochter, S. Singer
Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial
D. B. Raphael Daniela, N. S. Russell, E. van Werkhoven, J. M. Immink, D. P. G. Westhoff, M. C. Stenfert Kroese, M. R. Stam, L. M. van Maurik, C. M. J. van Gestel, T. van der Weijden, L. J. Boersma
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial
Manuela Rabaglio, Zhuoxin Sun, Rudolf Maibach, Anita Giobbie-Hurder, Bent Ejlertsen, Vernon J. Harvey, Patrick Neven, István Láng, Hervé Bonnefoi, Andrew Wardley, Barbara Ruepp, Monica Castiglione, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Marco Colleoni, Beat Thürlimann, Meredith M. Regan
The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements
Chirag Shah, April Zambelli-Weiner, Nicole Delgado, Ashley Sier, Robert Bauserman, Jerrod Nelms
Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14) trial
Rieneke T. Lugtenberg, Stefanie de Groot, Ad A. Kaptein, Maarten J. Fischer, Elma Meershoek-Klein Kranenbarg, Marjolijn Duijm-de Carpentier, Danielle Cohen, Hiltje de Graaf, Joan B. Heijns, Johanneke E. A. Portielje, Agnes J. van de Wouw, Alex L. T. Imholz, Lonneke W. Kessels, Suzan Vrijaldenhoven, Arnold Baars, Marta Fiocco, Jacobus J. M. van der Hoeven, Hans Gelderblom, Valter D. Longo, Hanno Pijl, Judith R. Kroep
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase
Jasgit C. Sachdev, Pamela Munster, Donald W. Northfelt, Hyo Sook Han, Cynthia Ma, Fiona Maxwell, Tiffany Wang, Bruce Belanger, Bin Zhang, Yan Moore, Arunthathi Thiagalingam, Carey Anders
Association between statin use and second cancer risk in breast cancer patients: a nationwide population-based cohort study
Yin-Che Lu, Da-Wei Huang, Pin-Tzu Chen, Ching-Fang Tsai, Mei-Chen Lin, Che-Chen Lin, Shi-Heng Wang, Yi-Jiun Pan
Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features
Adana A. M. Llanos, Song Yao, Amartya Singh, John B. Aremu, Hossein Khiabanian, Yong Lin, Coral Omene, Angela R. Omilian, Thaer Khoury, Chi-Chen Hong, Shridar Ganesan, David J. Foran, Michael J. Higgins, Christine B. Ambrosone, Elisa V. Bandera, Kitaw Demissie
Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis
Yaokai Wen, Xiangrong Wu, Haoxin Peng, Caichen Li, Yu Jiang, Zixuan Su, Hengrui Liang, Jun Liu, Jianxing He, Wenhua Liang
A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer
Christine Brezden-Masley, Kelly E. Fathers, Megan E. Coombes, Behin Pourmirza, Cloris Xue, Katarzyna J. Jerzak
Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer
Gwen M. H. E. Dackus, Katarzyna Jóźwiak, Elsken van der Wall, Paul J. van Diest, Michael Hauptmann, Sabine Siesling, Gabe S. Sonke, Sabine C. Linn
Inflammation markers on benign breast biopsy are associated with risk of invasive breast cancer in African American women
Asra N. Shaik, Katrin Kiavash, Karri Stark, Julie L. Boerner, Julie J. Ruterbusch, Hany Deirawan, Sudeshna Bandyopadhyay, Rouba Ali-Fehmi, Gregory Dyson, Michele L. Cote
Racial disparities in survival outcomes among breast cancer patients by molecular subtypes
Fangyuan Zhao, Brenda Copley, Qun Niu, Fang Liu, Julie A. Johnson, Thomas Sutton, Galina Khramtsova, Elisabeth Sveen, Toshio F. Yoshimatsu, Yonglan Zheng, Abiola Ibraheem, Nora Jaskowiak, Rita Nanda, Gini F. Fleming, Olufunmilayo I. Olopade, Dezheng Huo
Prevalence of germline variants in consensus moderate-to-high-risk predisposition genes to hereditary breast and ovarian cancer in BRCA1/2-negative Brazilian patients
Renan Gomes, Pricila da Silva Spinola, Ayslan Castro Brant, Bruna Palma Matta, Caroline Macedo Nascimento, Silvia Maria de Aquino Paes, Cibele Rodrigues Bonvicino, Anna Claudia Evangelista dos Santos, Miguel Angelo Martins Moreira
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function
Katia Khoury, Filipa Lynce, Ana Barac, Xue Geng, Chau Dang, Anthony F. Yu, Karen L. Smith, Christopher Gallagher, Paula R. Pohlmann, Raquel Nunes, Pia Herbolsheimer, Robert Warren, Monvadi B. Srichai, Mark Hofmeyer, Federico Asch, Ming Tan, Claudine Isaacs, Sandra M. Swain
The RAD51D c.82G>A (p.Val28Met) variant disrupts normal splicing and is associated with hereditary ovarian cancer
Ciyu Yang, Angela G. Arnold, Amanda Catchings, Vikas Rai, Zsofia K. Stadler, Liying Zhang
New anti-HER2 agents for brain metastasis: histology-agnostic weapons?
Paolo Tarantino, Aleix Prat, Giuseppe Curigliano
Letter to the editor regarding the article “Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer”
Xishan Chen, Kangwen Guo, Jiong Lin
Implant-based breast reconstruction: re-analysis of the odds ratio for skin flap necrosis
Andrea Messori, Laura Bartoli, Elisa Ferracane
Correction to: Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen
C. Louwrens Braal, Koen G. A. M. Hussaarts, Lieke Seuren, Esther Oomen‑deHoop, Peter de Bruijn, ·Stefan A. J. Buck, Monique E. M. M. Bos, Martine F. Thijs‑Visser, Hanneke J. M. Zuetenhorst, Daniëlle Mathijssen‑van Stein, Mijntje B. Vastbinder, Roelof W. F. van Leeuwen, Teun van Gelder, Stijn L. W. Koolen, Agnes Jager, Ron H. J. Mathijssen
Correction to: Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations
Matthew S. Katz, Linda McCall, Karla Ballman, Reshma Jagsi, Bruce G. Haffty, Armando E. Giuliano